Media Advisories



AACR President, Past Presidents, and Members Serve as Thought Leaders for The Atlantic’s “People v. Cancer”2009611/12/2018 2:12:34 PM Advisories/AllItems.aspx110False2018-11-12T14:00:00Z<div class="ExternalClassE4EBC1BD57794383833A2BC483E7342C"><p><b>WHAT&#58;&#160;<br></b>On Wednesday, November 14, The Atlantic will present “People v. Cancer,” a live event exploring how the collective oncology community is coming together in the fight against cancer. As the world’s first and largest cancer research organization, the American Association for Cancer Research (AACR) and many of its members, including AACR President Elizabeth Jaffee, MD, and Past Presidents Michael Caligiuri, MD, and Nancy Davidson, MD, will serve as thought leaders, conversing about the latest breakthroughs in cancer research, treatment, and care.&#160;&#160;</p><p><strong>WHEN&#58;<br></strong>Wednesday, November 14, 2018, 8 a.m. to 5 p.m.<br>For detailed agenda, visit <a href="http&#58;//" target="_blank">http&#58;//</a><br></p><p><b>WHERE&#58;&#160;<br></b>The Plaza Hotel, 58th Street and 5th Avenue, New York, New York<br>Grand Ballroom</p><p><b>WHO&#58;</b><br><strong>Elizabeth Jaffee, MD</strong>, President, AACR; Deputy Director, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins<br><strong>Michael Caligiuri, MD</strong>, AACR President 2017-2018; President and Physician-in-Chief, City of Hope National Medical Center<br><strong>Nancy Davidson, MD</strong>, AACR President 2016-2017; President and Executive Director, Seattle Cancer Care Alliance&#160;</p><p><em>*To interview Elizabeth Jaffee, Michael Caligiuri, or Nancy Davidson, contact Rachel Salis-Silverman.&#160;</em>&#160;<br></p><blockquote style="margin&#58;0px 0px 0px 40px;border&#58;none;padding&#58;0px;"><p><strong>Additional Speakers from the American Association for Cancer Research&#58;</strong></p></blockquote><ul><li>David Tuveson, MD, PhD, AACR Board of Directors; Cold Spring Harbor Lab<br></li><li>Nina Bhardwaj, MD, PhD, Icahn School of Medicine, Mount Sinai<br></li><li>Brian Czerniecki, MD, PhD, Moffitt Cancer Center&#160;<br></li><li>Tom Lynch, MD, Bristol-Myers Squibb<br></li><li>Vincent Miller, MD, Foundation Medicine<br></li><li>Brian Rivers, PhD, MPH, Morehouse School of Medicine<br></li><li>Nikhil Wagle, MD, Dana-Farber Cancer Institute<br></li><li>Jennifer Wargo, MD, MD Anderson&#160;<br></li><li>Jedd Wolchok, MD, PhD, Memorial-Sloan Kettering&#160;<br><br></li></ul></div>
30th EORTC-NCI-AACR SYMPOSIUM: Molecular Targets and Cancer Therapeutics2570410/30/2018 1:27:41 PM Advisories/AllItems.aspx109False2018-10-30T04:05:00Z<div class="ExternalClassF7794FA329E940A6A119364B19C0F115"><p>The 30th EORTC-NCI-AACR Symposium&#58; Molecular Targets and Cancer Therapeutics will be held Nov. 13-16 in Dublin, Ireland.</p><p>&#160;A press conference with dial-in facilities will take place at 12&#58;30 p.m. ET/5&#58;30 p.m. GMT on Tuesday, Nov. 13, Liffey room 2A, The Convention Centre, Dublin. This will include&#58;</p><div><ul><li><p>Suggestions and navigational tips from the Symposium scientific co-chairs Charles Swanton, MD, PhD; James Gulley, MD, PhD; and Antoni Ribas, MD, PhD, for sessions and presentations during the Symposium that the scientific committee think may be of interest to journalists.<br></p></li><li><p>Presentation by Laura van ‘t Veer, PhD, of her new findings from the I-SPY 2 trial to be presented on Wednesday. Details of this are embargoed to the start of the scientific session in which she will make her presentation&#58; 9&#58;30 a.m. ET/2&#58;30 p.m. GMT on Wednesday, Nov. 14.<br></p></li></ul></div><p>&#160;If you want to join the press conference by telephone please email Gwydion Lyn&#58; <a href="mailto&#58;"></a> (copying in Emma Mason/Kerry Noble&#58; <a href="mailto&#58;"></a>) to register your interest and receive dial-in details.<br></p><p>There will be a full media program and there is still time for journalists to register <a href="https&#58;//">online</a>.<br></p><p>You will need to register to join the press conference even if you are unable to attend the Symposium in Dublin.&#160;<br></p><p>The media program will include&#58;<br></p><div><ul><li><p>Latest results of the I-SPY 2 trial using genomic testing to identify breast cancer patients most likely to benefit from new drugs<br></p></li><li><p>Results from a trial matching anti-cancer drugs to patients according to tumor genetic abnormality rather than type of cancer<br></p></li><li><p>Results from a trial of a new oral drug to boost the effectiveness of radiotherapy for hard-to-treat cancers<br></p></li><li><p>What is the effectiveness of a new anti-HER2 drug for treating cancers of the gullet, stomach, and bowel?<br></p></li><li><p>The effect of combining immunotherapies to treat patients with non-small cell lung cancer<br></p></li><li><p>Difficult-to-treat bowel cancer&#58; how does it respond to a new combination of two immunotherapies?<br></p></li><li><p>“Significant” findings suggest effective, non-toxic treatment for aggressive childhood cancer<br></p></li><li><p>New drug combination used to treat patients with rare, incurable cancers of the digestive tract<br></p></li></ul></div><p>The European Organisation for Research and Treatment of Cancer (EORTC), the American Association for Cancer Research (AACR), and the National Cancer Institute (NCI) are joining forces for the <a href="https&#58;//">Symposium</a> where the latest advances in pre-clinical and clinical research will be presented. Around 1,500 international experts will be discussing innovations in drug development, target selection, and the impact of new discoveries in molecular biology.<br></p><p>For media queries about the Symposium, contact&#58;<br></p><p><br></p><p>EORTC media consultants&#58;</p><p>Emma Mason</p><p>Email&#58; <a href="mailto&#58;"></a></p><p>Tel&#58; +44 (0)1376 563090</p><p>Mobile&#58; +44 (0)7711 296 986</p><p>&#160;</p><p>Kerry Noble</p><p>Email&#58; <a href="mailto&#58;"></a></p><p>Mobile&#58; +44 (0)7446 869 433</p><p>&#160;</p><p>AACR media contact&#58;&#160;</p><p>Rick Buck</p><p>Email&#58; <a href="mailto&#58;"></a></p><p>Mobile&#58; +1 856 562 5668<br></p><p>&#160;</p><p>More information on the program is available on the EORTC-NCI-AACR Symposium <a href="https&#58;//" target="_blank">website</a>.<br></p><div><br></div></div>
Media Registration Open: 2018 San Antonio Breast Cancer Symposium, Dec. 4-82589710/17/2018 4:52:18 PM Advisories/AllItems.aspx108False2018-10-17T04:05:00Z<div class="ExternalClass8968FD8DD62F484B9812BE21B2D1943D"><p>SAN ANTONIO — UT Health San Antonio MD Anderson Cancer Center, the American Association for Cancer Research, and the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine will host the<a href="https&#58;//" target="_blank"> 2018 San Antonio Breast Cancer Symposium</a> (SABCS), Dec. 4-8, at the Henry B. González Convention Center.&#160;</p><p>SABCS features the latest research in the prevention, diagnosis, and treatment of premalignant breast disease and breast cancer, including data from late-breaking clinical trials. The symposium attracts more than 7,000 basic scientists, physician-scientists, clinical investigators and breast care providers, and advocates from almost 90 countries. This year’s program will include sessions on cancer genetics, artificial intelligence, under- and overtreatment, and much more. View the scientific program <a href="https&#58;//" target="_blank">here</a>.&#160;<br></p><p>Complimentary registration is available to members of the media who provide credentials. For more information or to register for the meeting, please contact Julia Gunther at <a href="mailto&#58;"></a> or 215-446-6896 or Jill Byrd at <a href="mailto&#58;"></a> or 210-501-4288.&#160;</p><p>To reserve a hotel room, please visit the <a href="https&#58;//">SABCS website</a>.&#160;&#160;</p><p>A press kit containing news releases and highlighted abstracts will be available in late November.&#160;&#160;</p><p>Follow the meeting on Twitter&#58; <a href="https&#58;//" target="_blank">#SABCS18</a><br></p></div>
AACR to Host Indoor Cycling Event to Raise Funds for Cancer Research2464010/4/2018 1:37:20 PM Advisories/AllItems.aspx107False2018-10-03T04:05:00Z<div class="ExternalClass34F34465097146DB8757D644607B18B2"><p style="text-align&#58;center;text-decoration&#58;underline;">​<strong style="font-size&#58;24px;">Media Advisory&#160;</strong></p><div><br></div><div><strong>WHAT&#58;&#160;</strong> &#160;&#160;</div><div>The American Association for Cancer Research to host&#160;Revolutions for Research, an indoor cycling event dedicated to raising funds for life-saving cancer research. Participants will pedal to beat cancer as a team or solo for a 90- or 180-minute session.&#160;<br></div><div>&#160;</div><div>&#160;</div><div><strong>WHO&#58;&#160; &#160;</strong> &#160; &#160; &#160; &#160;&#160;<br></div><div>Madeleine Duey, AACR Foundation Ambassador and Cancer&#160;Survivor;<br></div>Sarah Happy, AACR Foundation Ambassador and Cancer Survivor;<br>Mitch Stoller, AACR Foundation Executive Director; and<br><div>More than 100 people including cancer patients, survivors, community members and families.</div><div>&#160;</div><div>&#160;</div><div><strong>WHEN&#58;&#160;</strong> &#160;&#160; &#160; &#160; &#160;&#160;</div><div>Saturday, October 6, 2018</div>Wave 1&#58; 8&#58;00 a.m. - 9&#58;30 a.m.<br>Wave 2&#58; 9&#58;30 a.m. - 11&#58;00 a.m.<br>Intense rider/teams&#58; 8am - 11am<br><blockquote style="margin&#58;0px 0px 0px 40px;border&#58;none;padding&#58;0px;"><blockquote style="margin&#58;0px 0px 0px 40px;border&#58;none;padding&#58;0px;"><div>&#160;</div></blockquote></blockquote><div>&#160;<br></div><div><strong>WHERE&#58;</strong>&#160; &#160; &#160; &#160; &#160;&#160;</div><div>The Fillmore Philadelphia</div><div>29 F Allen St.&#160;</div><div>Philadelphia, PA 19123<br></div></div>
AACR to Host a Congressional Briefing to Unveil the AACR Cancer Progress Report 2018255409/12/2018 1:06:00 PM Advisories/AllItems.aspx105False2018-09-12T04:05:00Z<div class="ExternalClass38730240A56344C392B773CE8FD86B7D"><p><strong>WHAT&#58;&#160; &#160; &#160;</strong>&#160; &#160; &#160;<br>American Association for Cancer Research (AACR) to host a Congressional briefing to unveil the <em>AACR Cancer Progress Report 2018</em>.&#160;</p><p>In its eighth year, the AACR Cancer Progress Report showcases progress against cancer from the past year, and underscores the importance of robust, sustained, and predictable growth in funding for the National Institutes of Health, National Cancer Institute, U.S. Food and Drug Administration, and Cancer Prevention and Control Programs at the Centers for Disease Control and Prevention.</p><p><strong>WHO&#58;&#160; </strong>&#160; &#160; &#160;<br>U.S. Rep. Ted Poe (R-Texas 2nd District)</p><p>Elizabeth Jaffee, MD, President, American Association for Cancer Research;&#160;<em>Chair, AACR Cancer Progress Report 2018</em>; Deputy Director, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore<br></p><p>Margaret Foti, PhD, MD (hc), CEO, American Association for Cancer Research, Philadelphia&#160;</p><p>Quynh-Thu Le, MD, Professor and Chair, Department of Radiation Oncology, Stanford Cancer Institute, Palo Alto, California</p><p style="text-decoration&#58;underline;">Survivor Stories from the <em>AACR Cancer Progress Report 2018</em>&#58;</p><p>Chuck Dandridge, survivor of acute myeloid leukemia, Mansfield, Texas</p><p>Tori Lee, pediatric cancer survivor of acute lymphoblastic leukemia with Tori’s parents, Dana and Chris Lee, Oakhurst, New Jersey</p><p>Laurie Trotman, survivor of breast cancer, Hoover, Alabama</p><p><strong>WHEN&#58;&#160; &#160; </strong>&#160; &#160; &#160; <br>Wednesday, September 12, 2018<br><strong>12 p.m. to 1&#58;30 p.m.</strong></p><p>For in-person attendance, please RSVP to Rachel Salis-Silverman, <a href="mailto&#58;"></a>.&#160;&#160;</p><p><strong>WHERE&#58;&#160; &#160; </strong>&#160; &#160;<br>Rayburn House Office Building<br>The Gold Room (Room 2168)<br>Capitol Hill</p><p><em>Briefing is in cooperation with U.S. Representative Kevin Yoder (R-Kansas).</em></p></div>
Congressional Leaders and NIH Director Francis Collins to Speak at Rally for Medical Research 255429/12/2018 1:05:37 PM Advisories/AllItems.aspx106False2018-09-12T04:05:00Z<div class="ExternalClass962031C1036742E09E759ABC05A5F00A"><p>​Nearly 350 organizations will converge on Capitol Hill for Rally for Medical Research Hill Day on September 12 and 13 to advocate for robust, sustained, and predictable annual funding increases for the National Institutes of Health (NIH). Specifically, advocates will express their appreciation to Senate offices for passing a bill with a $2 billion funding increase for the NIH in fiscal year (FY) 2019, while requesting that the House of Representatives support the Senate-passed funding level of $39.1 billion for the NIH in the final FY 2019 Labor-HHS-Education Appropriations Bill.</p><p>The media is invited to cover the following events&#58;<br></p><p><b>A Reception to Celebrate the Lifesaving Science Supported by the NIH<br></b>Wednesday, September 12, 4&#58;30 p.m. to 7 p.m.<br>Dirksen Senate Office Building, Room G50<br>Moderated by Elizabeth Jaffee, President of the American Association for Cancer Research (AACR) and Deputy Director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University</p><p>Confirmed Speakers&#58;<br>Francis S. Collins, MD, PhD, Director, National Institutes of Health<br>Senator Roy Blunt (R-Missouri)<br>Senator Patty Murray (D-Washington)<br>U.S. Rep. Kevin Yoder (R-Kansas)<br></p><p><b>Rally for Medical Research Breakfast Program<br></b>Thursday, September 13, 8 a.m.<br>Watergate Hotel, 2650 Virginia Ave., NW, Washington, D.C.<br>Moderated by Margaret Foti, PhD, MC (hc), Chief Executive Officer of the American Association for Cancer Research (AACR)</p><p>Confirmed Speakers&#58;<br>U.S. Rep. Debbie Wasserman Schultz (D-Florida)<br>U.S. Rep. Jamie Raskin (D-Maryland)</p><p><strong>About Rally for Medical Research Hill Day<br></strong>The Rally for Medical Research initiative was launched in April 2013 to bring together the entire medical research community to ask Congress to make the NIH a national priority. Through the annual Hill Day, the Rally for Medical Research continues to raise awareness about the critical need for an increased investment in the NIH to improve health, spur progress, inspire hope, and save more lives.</p><p>Following more than a decade of NIH budgets that failed to keep up with the rate of biomedical inflation, Congress has redoubled its efforts to support lifesaving research by boosting the NIH budget by a remarkable $7 billion (23 percent) since FY 2015. For the benefit of all those who continue to await better therapies and even cures, this momentum must continue.</p><p>This investment is enabling researchers at universities and research institutions in all 50 states to pursue emerging scientific opportunities to address the nation’s most pressing health needs. In addition to bringing hope and improving the quality of life for patients, the ongoing success of the medical research enterprise also drives local and national economic activity, strengthens U.S. competitiveness in an increasingly innovation-based global marketplace, and inspires future generations of scientists to commit to careers in research.<br></p></div>
Media Registration: Cancer Immunotherapy Conference in New York 251907/31/2018 8:03:48 PM Advisories/AllItems.aspx104False2018-07-31T04:00:00Z<div class="ExternalClassA5FCB38FBF8A41D48DE08E23AB1EDEA6"><p>NEW YORK – The Cancer Research Institute (CRI), the Association for Cancer Immunotherapy (CIMT), the European Academy of Tumor Immunology (EATI), and the American Association for Cancer Research (AACR) will sponsor the fourth <a href="http&#58;//">International Cancer Immunotherapy Conference</a> at the New York Marriott Marquis in New York City, Sept. 30-Oct. 3, 2018.<br></p><p>The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field. The conference will cover all areas of inquiry in cancer immunology and immunotherapy, including&#58; regulating T cells; the tumor microenvironment; genetically engineered T cells; the effects of targeted and immune therapies on immune balance; novel vaccine platforms and combinations; predicting response to immunotherapy; the convergence of technology and cancer immunotherapy; and the microbiome and metabolism.<br></p><p>The full program is available <a href="http&#58;//">here</a>.<br></p><p><strong>Registration is complimentary for credentialed news media. Contact </strong><a href="mailto&#58;"><strong></strong></a><strong> to register.&#160;</strong><br></p><p>Cancer center public information officers and communications staff can also register by contacting <a href="mailto&#58;"></a>.&#160;<br></p><p>Those following on social media can join the conversation on Twitter at <a href="mailto&#58;">#cicon18</a>.<br></p><p><br></p><p>For more information, contact the AACR public relations team&#58;<br></p><p>Rachel Salis-Silverman<br></p><p>Director</p><p>215-446-7159</p><p>Cell&#58; 267-970-3685</p><p></p><a href="mailto&#58;"><p><br></p></a><p>&#160;</p><p>Julia Gunther</p><p>Assistant Director&#160;</p><p>215-446-6896</p><p>Cell&#58; 770-403-7690</p><p><a href="mailto&#58;"></a></p><p>&#160;</p><p>Sarah Cohn</p><p>Manager</p><p>215-446-8754</p><p>Cell&#58; 856-397-0314</p><p></p><a href="mailto&#58;"><p><br></p></a><p>&#160;</p><p>Charmaine Riley</p><p>Senior Coordinator</p><p>215-309-4347</p><p>Cell&#58; 360-789-5147</p><p><a href="mailto&#58;"></a><br></p></div>
Video Available: AACR Hosts Congressional Briefing on the Alarming Rise of E-cigarette Use in Youth250717/19/2018 8:35:07 PM Advisories/AllItems.aspx103False2018-07-19T20:30:00Z<div class="ExternalClass5AAEA9BA0A06458081E93C9FB8F62AA8"><p>WASHINGTON, D.C. – Scientists from the American Association for Cancer Research (AACR), along with an expert from the federal government, an official from a local school district, and a writer from The New Yorker, addressed congressional staffers and the public on Wednesday, July 18 at a briefing titled “E-cigarettes&#58; Striking a Balance Between Preventing Youth Nicotine Addiction and Helping Current Smokers Quit Combustible Cigarettes.”&#160;</p><p>The panelists presented the latest available science on the effects and content of e-cigarettes and suggested approaches to halting the concerning rise in youth vaping and nicotine addiction.&#160;</p><p>A video of the full briefing is available here&#58; <a href="https&#58;//" target="_blank">https&#58;//</a></p><p>You can read a summary of the briefing on the AACR’s blog&#58; <a href="https&#58;//" target="_blank">https&#58;//</a></p><p>Sen. Dick Durbin (D-Illinois) and Rep. Jackie Speier (D-California) were the honorary congressional co-chairs. In inspiring opening remarks, Durbin discussed how the loss of his father to lung cancer sparked his passion for ending the scourge of tobacco.</p><p>Roy S. Herbst, MD, PhD, chair of the AACR’s Tobacco and Cancer Subcommittee and chief of medical oncology at the Yale Cancer Center, moderated the briefing. Other speakers included&#58;</p><ul><li>Rachel Grana Mayne, PhD, MPH, a program director in the Tobacco Control and Research Branch at the National Cancer Institute and an expert on e-cigarette research;<br><br></li><li>Brian Maslowski, an alcohol, tobacco, and other drug instructor from the Fairfax County Public Schools’ Office of Student Safety and Wellness with a wealth of direct experience on the context in which high school and middle school students are using e-cigarettes;<br><br></li><li>Jia Tolentino, a staff writer at The New Yorker, whose recent in-depth article, “The Promise of Vaping and the Rise of Juul,” chronicled the recent rise of “juuling” among high school and college students; and<br><br></li><li>Benjamin Toll, PhD, member of the AACR’s Tobacco and Cancer Subcommittee and chief of Tobacco Cessation and Health Behaviors at the Hollings Cancer Center, an expert on novel smoking cessation treatments.</li></ul><p>To schedule interviews with the panelists, contact Julia Gunther at <a href="mailto&#58;"></a> or 215-446-6896.<br></p></div>
Webcasts Available: Renowned Cancer Researchers Present at the AACR’s International Lymphoma Meeting in Boston198406/28/2018 6:13:31 PM Advisories/AllItems.aspx102False2018-06-27T04:00:00Z<div class="ExternalClass8C2D60CB91F14E0483A887F9E3E294CC"><p>The American Association for Cancer Research (AACR) recently hosted the<a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=147"> Inaugural AACR International Meeting&#58; Advances in Malignant Lymphoma</a> in Boston. Presented in cooperation with the International Conference on Malignant Lymphoma (ICML), the program provided a forum for discussion and brainstorming about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.&#160;<br></p><p>The meeting featured keynote addresses from several renowned cancer researchers. Their presentations are now available as webcasts&#58;<br></p><div><ul><li><p>Michael Caligiuri, MD, AACR Past President and City of Hope National Medical Center, presented a talk titled “Immunogenicity Predicts Prevention.&quot;&#160;<a href="http&#58;//" target="_blank">Watch&#160;the webcast</a>. <br></p></li></ul></div><div><ul><li><p>James Allison, PhD, The University of Texas MD Anderson Cancer Center, presented a talk titled “Immune Checkpoint Blockade in Cancer Therapy&#58; New Insights, Opportunities, and Prospects for Cures.” <a href="http&#58;//" target="_blank">Watch&#160;the webcast</a>.&#160;<br></p></li></ul></div><div><ul><li><p>Kenneth Anderson, MD, Dana-Farber Cancer Institute, presented a talk titled “Targeting Achilles’ Heels in Multiple Myeloma.&quot; <a href="http&#58;//" target="_blank">Watch&#160;the webcast. </a><br></p></li></ul></div><p>Interviews with these experts, meeting chair Ari Melnick, MD, or others who presented at this meeting can be arranged. Contact Julia Gunther at <a href="mailto&#58;"></a> or 215-446-6896.<br></p><p><a href="http&#58;//">Read a Q&amp;A </a>with Dr. Melnick about the meeting on the AACR’s blog, <em>Cancer Research Catalyst.</em>&#160;<br></p><p>See the <a href="/Meetings/Pages/MeetingDetail.aspx?EventItemID=147&amp;DetailItemID=756">full program</a>&#160;and the <a href="http&#58;//" target="_blank">abstracts</a>.</p><div><br></div></div>
AACR to Host Inaugural International Meeting on Advances in Malignant Lymphoma198396/11/2018 9:05:20 PM Advisories/AllItems.aspx101False2018-06-11T20:45:00Z<div class="ExternalClass31104E45BF8A48C290E123D3BED1DB51"><p>​The American Association for Cancer Research (AACR) will host its <a href="http&#58;//;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=eXqEJl1NfqkXiU1xcA78JEtrwfT5VyAQJu5yuSpKUU8" target="_blank">Inaugural AACR International Meeting&#58; Advances in Malignant Lymphoma</a> later this month in Boston. Presented in cooperation with the International Conference on Malignant Lymphoma (ICML), this program will provide a forum for discussion and brainstorming about how recent advances and emerging areas of lymphoma research hold enormous potential for transforming clinical care.&#160;</p><p>The meeting is designed to be highly interactive and presents a unique opportunity to engage with international leaders in lymphoma research. Topics to be discussed include immunotherapy, targeted therapy, CRISPR screening, liquid biopsy, and studying canine lymphoma to develop treatments that will benefit dogs and humans.</p><p>The program will feature keynote addresses from renowned cancer researchers&#58;</p><p>On Friday, June 22, from 6-8 p.m. ET,<br><strong>•&#160;Michael Caligiuri, MD</strong>, City of Hope National Medical Center and Past President of the AACR, will present a talk titled “Immunogenicity Predicts Prevention,” and<br><strong>•&#160;Carl June, MD</strong>, University of Pennsylvania and member of the AACR Board of Directors, will present a talk titled “CAR T for Lymphoma and Beyond.”</p><p>On Tuesday, June 26, from 8-10 a.m. ET, <br><strong>•&#160;James Allison, PhD</strong>, The University of Texas MD Anderson Cancer Center, will present a talk titled “Immune Checkpoint Blockade in Cancer Therapy&#58; New Insights, Opportunities, and Prospects for Cures,” and <br><strong>•&#160;Kenneth Anderson, MD</strong>, Dana-Farber Cancer Institute, will present a talk titled “Targeting Achilles Heels in Multiple Myeloma.”</p><p>The keynote addresses will be available as webcasts within 24 hours of presentation.</p><p>Reporters may register for the meeting and complimentary access to the webcasts by contacting Julia Gunther at <a href="mailto&#58;"></a> or 215-446-6896.</p><p>To learn more about the meeting, watch <a href="http&#58;//;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=https&#58;//;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=ZMDBs2djYOigaMX66rLkc6JEDcFdvrMi5EOIDIWXSQc" target="_blank">this interview </a>with meeting chair Ari Melnick, MD. Visit the meeting website <a href="http&#58;//;H=oGJ1pkZyysOST8btnWeAdWfazdP60O3PLkuOZioW2RiI0IVhceklygFHMnqT9mcAyt1hDCcUrpx48F75qhgyFQZ06iVCinohqzd/kJiWMHKzq2gJYUgmOweRaVRw9vyq&amp;G=0&amp;R=http&#58;//;I=20180611203722.00000058b635%40mail6-94-usnbn1&amp;X=MHwxMDQ2NzU4OjViMWVkZDJhNmZiMjNkMGEwOTQzY2Y0MDs%3D&amp;S=wthwbsgE7FLyq7gz24JLqGhbUxu3MDq3-phTh2AFMUk">here</a>.</p><p><strong>WHEN&#58;</strong><br>June 22-26, 2018</p><p><strong>WHERE&#58;</strong><br>Boston Marriott Copley Place <br>110 Huntington Avenue<br>Boston, MA 02116</p><p><strong>PROGRAM&#58;</strong><br>Read the full program here.<br>Interviews can be arranged per the availability of the speakers.</p></div>